The panograph in cancer patients receiving myelosuppressive chemotherapy.

被引：0
|
作者：
Catanzano, J [1 ]
Weikel, D [1 ]
Favilla, E [1 ]
Elsabagh, A [1 ]
Overholser, C [1 ]
Meiller, T [1 ]
机构：
[1] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
来源：
JOURNAL OF DENTAL RESEARCH | 1998年 / 77卷
关键词：
D O I：
暂无
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
11
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [41] Thromboelastometry in patients receiving platelet transfusion after chemotherapy.
    Dehmel, H
    Tiede, A
    Horter, S
    Causer, A
    von Depka, M
    BLOOD, 2004, 104 (11) : 987A - 987A
  • [42] A study of taste change strategies in patients receiving chemotherapy.
    Rehwaldt, M
    Purl, S
    Tariman, J
    Blendowski, C
    Shott, S
    Wickham, R
    ONCOLOGY NURSING FORUM, 2006, 33 (02) : 467 - 467
  • [43] Nursing care and management of patients receiving intraperitoneal chemotherapy.
    Marin, K
    Loving, N
    Muehlbauer, P
    ONCOLOGY NURSING FORUM, 2006, 33 (02) : 435 - 436
  • [44] Phase II dose-finding study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapy
    Gladkov, Oleg
    Moiseyenko, Vladimir
    Bondarenko, Igor N.
    Shparyk, Yaroslav
    Barash, Steven
    Adar, Liat
    Bias, Peter
    Avisar, Noa
    MEDICAL ONCOLOGY, 2015, 32 (06)
  • [45] Sarcopenia as a predictor of chemotherapy toxicity in patients with ovarian cancer receiving platinum and taxane-based chemotherapy.
    Tucker, Katherine
    Staley, Stuart-Allison Moffat
    Newton, Meredith
    Ertel, Michelle
    Zhang, Yingao
    Doherty, Irene
    Gehrig, Paola A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [46] The development of a prediction tool for chemotherapy-induced anemia in breast cancer patients receiving adjuvant chemotherapy.
    Dranitsaris, G
    Clemons, M
    Verma, S
    Vincent, M
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S106 - S106
  • [47] Phase II dose-finding study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapy
    Oleg Gladkov
    Vladimir Moiseyenko
    Igor N. Bondarenko
    Yaroslav Shparyk
    Steven Barash
    Liat Adar
    Peter Bias
    Noa Avisar
    Medical Oncology, 2015, 32
  • [48] SURVIVAL IN STAGE IV COLON CANCER FOR PATIENTS RECEIVING NEOADJUVANT VS ADJUVANT CHEMOTHERAPY.
    Hota, S.
    Parascandola, S.
    Tampo, M. T.
    Sparks, A.
    Obias, V.
    DISEASES OF THE COLON & RECTUM, 2020, 63 (06) : E359 - E359
  • [49] Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy.
    Shayne, M.
    Culakova, E.
    Wolff, D. A.
    Poniewierski, M. S.
    Lyman, G. H.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S281 - S282
  • [50] Neutropenia-Associated Outcomes in Patients With Breast Cancer Receiving Myelosuppressive Chemotherapy With Reduced Doses of Pegfilgrastim
    Moore, Donald C.
    Gebru, Tsion
    Pellegrino, Annie
    Fasan, Adenike
    Patel, Jolly
    Ringley, J. Tanner
    JOURNAL OF PHARMACY PRACTICE, 2020, 33 (06) : 779 - 783
12345